These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 33453388)
21. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery. Kawadkar J; Pathak A; Kishore R; Chauhan MK Drug Dev Ind Pharm; 2013 Apr; 39(4):569-78. PubMed ID: 22639934 [TBL] [Abstract][Full Text] [Related]
22. Development, in vitro and in vivo evaluation of miltefosine loaded nanostructured lipid carriers for the treatment of Cutaneous Leishmaniasis. Khan AS; Ud Din F; Ali Z; Bibi M; Zahid F; Zeb A; Mujeeb-Ur-Rehman ; Khan GM Int J Pharm; 2021 Jan; 593():120109. PubMed ID: 33253802 [TBL] [Abstract][Full Text] [Related]
23. Enhancement of bioavailability through transdermal drug delivery of paliperidone palmitate-loaded nanostructured lipid carriers. Raval S; Jani P; Patil P; Thakkar P; Sawant K Ther Deliv; 2021 Aug; 12(8):583-596. PubMed ID: 34286598 [No Abstract] [Full Text] [Related]
24. Tacrolimus-loaded nanostructured lipid carriers for oral delivery-in vivo bioavailability enhancement. Khan S; Shaharyar M; Fazil M; Hassan MQ; Baboota S; Ali J Eur J Pharm Biopharm; 2016 Dec; 109():149-157. PubMed ID: 27793753 [TBL] [Abstract][Full Text] [Related]
25. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization, Patel MH; Mundada VP; Sawant KK Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488 [No Abstract] [Full Text] [Related]
26. Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout. Ali Z; Din FU; Zahid F; Sohail S; Imran B; Khan S; Malik M; Zeb A; Khan GM BMC Pharmacol Toxicol; 2022 Nov; 23(1):86. PubMed ID: 36443818 [TBL] [Abstract][Full Text] [Related]
27. Selenium-coated nanostructured lipid carriers used for oral delivery of berberine to accomplish a synergic hypoglycemic effect. Yin J; Hou Y; Yin Y; Song X Int J Nanomedicine; 2017; 12():8671-8680. PubMed ID: 29263662 [TBL] [Abstract][Full Text] [Related]
28. Bioavailability enhancement of vitamin E TPGS liposomes of nintedanib esylate: formulation optimization, cytotoxicity and pharmacokinetic studies. Kala SG; Chinni S Drug Deliv Transl Res; 2022 Nov; 12(11):2856-2864. PubMed ID: 35322372 [TBL] [Abstract][Full Text] [Related]
29. Formulation, Characterization, and Pharmacokinetic Studies of 6-Gingerol-Loaded Nanostructured Lipid Carriers. Wei Q; Yang Q; Wang Q; Sun C; Zhu Y; Niu Y; Yu J; Xu X AAPS PharmSciTech; 2018 Nov; 19(8):3661-3669. PubMed ID: 30324361 [TBL] [Abstract][Full Text] [Related]
30. Nanostructured Lipid Carriers for Oral Bioavailability Enhancement of Exemestane: Formulation Design, In Vitro, Ex Vivo, and In Vivo Studies. Singh A; Neupane YR; Mangla B; Kohli K J Pharm Sci; 2019 Oct; 108(10):3382-3395. PubMed ID: 31201904 [TBL] [Abstract][Full Text] [Related]
31. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s). Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192 [TBL] [Abstract][Full Text] [Related]
32. Enhanced intestinal absorption of curcumin in Caco-2 cell monolayer using mucoadhesive nanostructured lipid carriers. Chanburee S; Tiyaboonchai W J Biomed Mater Res B Appl Biomater; 2018 Feb; 106(2):734-741. PubMed ID: 28323388 [TBL] [Abstract][Full Text] [Related]
33. Improving intestinal absorption and oral bioavailability of curcumin via taurocholic acid-modified nanostructured lipid carriers. Tian C; Asghar S; Wu Y; Chen Z; Jin X; Yin L; Huang L; Ping Q; Xiao Y Int J Nanomedicine; 2017; 12():7897-7911. PubMed ID: 29138557 [TBL] [Abstract][Full Text] [Related]
34. Repaglinide-loaded nanostructured lipid carriers with different particle sizes for improving oral absorption: preparation, characterization, pharmacokinetics, and Wu L; Zhao L; Su X; Zhang P; Ling G Drug Deliv; 2020 Dec; 27(1):400-409. PubMed ID: 31729898 [TBL] [Abstract][Full Text] [Related]
35. Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption. Zhou X; Zhang X; Ye Y; Zhang T; Wang H; Ma Z; Wu B Int J Pharm; 2015 Feb; 479(2):391-8. PubMed ID: 25556104 [TBL] [Abstract][Full Text] [Related]
36. Formulation of intranasal surface engineered nanostructured lipid carriers of rotigotine: Full factorial design optimization, in vitro characterization, and pharmacokinetic evaluation. Zafar A; Awad Alsaidan O; Alruwaili NK; Sarim Imam S; Yasir M; Saad Alharbi K; Singh L; Muqtader Ahmed M Int J Pharm; 2022 Nov; 627():122232. PubMed ID: 36155794 [TBL] [Abstract][Full Text] [Related]
37. Preparation of tripterine nanostructured lipid carriers and their absorption in rat intestine. Zhou L; Chen Y; Zhang Z; He J; Du M; Wu Q Pharmazie; 2012 Apr; 67(4):304-10. PubMed ID: 22570936 [TBL] [Abstract][Full Text] [Related]
38. Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide. Zhang T; Chen J; Zhang Y; Shen Q; Pan W Eur J Pharm Sci; 2011 Jun; 43(3):174-9. PubMed ID: 21530654 [TBL] [Abstract][Full Text] [Related]
39. QbD-Steered Development of Biotin-Conjugated Nanostructured Lipid Carriers for Oral Delivery of Chrysin: Role of Surface Modification for Improving Biopharmaceutical Performance. Sharma T; Katare OP; Jain A; Jain S; Chaudhari D; Borges B; Singh B Colloids Surf B Biointerfaces; 2021 Jan; 197():111429. PubMed ID: 33130524 [TBL] [Abstract][Full Text] [Related]
40. Rifampicin loaded mannosylated cationic nanostructured lipid carriers for alveolar macrophage-specific delivery. Song X; Lin Q; Guo L; Fu Y; Han J; Ke H; Sun X; Gong T; Zhang Z Pharm Res; 2015 May; 32(5):1741-51. PubMed ID: 25407545 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]